Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Multiple Sclerosis Journal 17.5 (2011): S. 578-593. 08.11.2012
- Schlagwort
-
-
Iatrogene Krankheit
Therapie
Compliance
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2012
- Beteiligte Personen und Organisationen
-
Cook, S.
Vermersch, P.
Comi, G.
Giovannoni, G.
Rammohan, K.
Rieckmann, Peter
Soelberg Sørensen, P.
Hamlett, A.
Miret, M.
Weiner, J.
Viglietta, V.
Musch, B.
Greenberg, S. J.
- URN
-
urn:nbn:de:bvb:29-opus-38638
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cook, S.
- Vermersch, P.
- Comi, G.
- Giovannoni, G.
- Rammohan, K.
- Rieckmann, Peter
- Soelberg Sørensen, P.
- Hamlett, A.
- Miret, M.
- Weiner, J.
- Viglietta, V.
- Musch, B.
- Greenberg, S. J.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2012
Ähnliche Objekte (12)
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Multiple sclerosis
Multiple sclerosis
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
Pediatric Multiple Sclerosis
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Multiple sclerosis
Multiple sclerosis
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers
Pediatric Multiple Sclerosis
Cladribine Tablets for Relapsing–Remitting Multiple Sclerosis: A Clinician’s Review
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4
The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
Multiple sclerosis
Multiple sclerosis
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study
Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
Treatment with Cladribine Tablets Beyond Year 4: A Position Statement by Southeast European Multiple Sclerosis Centers